Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (8)
  • 2025 (26)
  • 2024 (21)
  • 2023 (47)
  • 2022 (65)
  • 2021 (56)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4152)
  • Synthetic drugs (1117)
  • Guns/Weapons (1025)
  • OCDETF/Task Force (818)
  • Fake Pills (676)
  • Arrests/Convictions - Major (632)
  • Guilty Plea (548)
  • Seizures (Drugs/Property) (475)
  • Prescription Drugs (371)
  • Overdose (326)
  • Major Law Enforcement Operation (275)
  • Diversion Division (254)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (236)
  • Money Laundering (214)
  • Gangs (200)
  • Outreach/Drug Prevention (187)
  • Fentanyl Awareness (163)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (33)
  • Fentanyl Free America (31)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Intergovernmental Affairs (9)
  • Critical Incident (8)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Other (12)
  • Cartel (1)

Drug Name

  • Oxycodone (48)
  • Opioids (45)
  • Fentanyl (30)
  • Hydromorphone (15)
  • Synthetic Opioids (13)
  • Morphine (8)
  • Benzodiazepines (7)
  • Cocaine (4)
  • Methamphetamine (4)
  • Heroin (3)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • GHB (1)
  • Marijuana (Cannabis) (1)

Field Division

  • Washington, DC (36)
  • St. Louis (32)
  • Chicago (22)
  • New York (21)
  • Miami (18)
  • Atlanta (12)
  • El Paso (11)
  • New Jersey (11)
  • Sede (10)
  • Seattle (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Los Angeles (6)
  • Louisville (6)
  • New Orleans (6)
  • New England (5)
  • San Diego (5)
  • Omaha (3)
  • Rocky Mountain (3)
  • Phoenix (2)
  • Philadelphia (1)
Clear All Results
241 Results - Showing 1 to 10
PRESS RELEASE

Maryland U.S. Attorney Announces Hundreds of Arrests Connected to Joint Federal-State Targeted Baltimore Criminal Enforcement Operation

Baltimore, Maryland – The U.S. Attorney’s Office for the District of Maryland announced federal charges today, in connection with a large-scale, targeted law-enforcement operation, resulting in hundreds of federal and state arrests. From January 20, through January 31, federal, state, and local law enforcement partners brought dozens of federal and...
PRESS RELEASE

Jacksonville Man Indicted for Violating Anti-Doping Law

Orlando, FL. – Paul Alexander Askew (46, Jacksonville) has been charged by a federal indictment with conspiracy to influence major international sports competition by doping. If convicted, Askew faces a maximum penalty of 10 years in federal prison. The indictment also notifies Askew that the United States intends to forfeit...
PRESS RELEASE

DEA Issues Immediate Suspension Order to Kentucky Pharmaceutical Distributor Over Controlled Substances Act Violations

LOUISVILLE, Ky. – Earlier today, the U.S. Drug Enforcement Administration issued an Immediate Suspension Order (ISO) to Richie Pharmacal, a pharmaceutical distributor in Glasgow, Kentucky. An ISO is an emergency administrative action that immediately suspends a DEA registrant's authority to handle controlled substances, due to imminent danger to public health...
PRESS RELEASE

Former Anesthesiology Resident Who Worked at Seattle Children's, UW Medicine, and Harborview Medical Center, Sentenced for Stealing and Using Narcotic Pain Medicine While on Duty

SEATTLE – A 36-year-old former anesthesiology resident at Seattle Children’s Hospital and Harborview and University of Washington Medical Centers was sentenced today in U.S. District Court in Seattle to one year of supervised release including 200 hours of community service for diverting narcotic pain medication to his own use while...
PRESS RELEASE

DEA Announces New Los Angeles Field Division Special Agent in Charge

LOS ANGELES – The U.S. Drug Enforcement Administration’s Los Angeles Field Division has new leadership. DEA Administrator Terrance C. Cole has appointed Anthony Chrysanthis as the Special Agent in Charge (SAC), covering Southern California, Nevada, Hawaii and the U.S. Territories of Guam and Saipan. Special Agent in Charge Chrysanthis draws...
PRESS RELEASE

El Paso Doctor Enters $200,000 Settlement Following State and Federal Fraud Allegations

EL PASO, Texas – Dr. Brian August, located in El Paso, has agreed to pay $200,000 to resolve allegations that he violated the Controlled Substances Act, the False Claims Act, and the Texas Health Care Program Fraud Prevention Act. The allegations involved the issuance of 255 controlled substance prescriptions to...
PRESS RELEASE

Portland Veterinarian Sentenced for Diverting Controlled Substances for Personal Use

PORTLAND, Ore. — Dr. Brenda Brown-Carlson, a Portland veterinarian, was sentenced to 60 months of supervised probation on January 13, 2026, in Multnomah County Circuit Court as part of a plea agreement. Brown-Carlson admitted to diverting controlled substances for her personal use and replacing them with saline, impacting the treatment...
PRESS RELEASE

DEA Chicago Field Division Welcomes New Special Agent in Charge

CHICAGO – Drug Enforcement Administration Administrator Terrance C. Cole has appointed Todd C. Smith as the new Special Agent in Charge (SAC) of the DEA Chicago Field Division. SAC Smith succeeds Shane R. Catone, who was appointed by DEA Administrator Cole as the Associate Chief of Operations (ACO) for the...
PRESS RELEASE

Panama City Man Sentenced to Federal Prison for Threatening Federal Informant

PENSACOLA, FLORIDA – Thomas Zachary Breeding, 41, of Panama City, FL, was sentenced to a total of 77 months in prison after he pleaded guilty to retaliation against a federal informant, transmission of threatening communications in interstate commerce, and supervised release violations. The sentence was announced by John P. Heekin...
PRESS RELEASE

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

Note: View the Settlement Agreement ALBUQUERQUE – The United States has reached a civil settlement with Luis Carlos Cordova, operator of Limitless Aesthetics and Healthcare in Santa Teresa, New Mexico, to resolve allegations that he failed to meet federal controlled-substance recordkeeping requirements under the Controlled Substances Act. According to the...

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Página 9
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster